title: Pharmacist-managed antimicrobial stewardship program for patients discharged from the emergency department.
abstract: Positive outcomes of antimicrobial stewardship programs in the inpatient setting are well documented, but the benefits for patients not admitted to the hospital remain less clear. This report describes a retrospective case-control study of patients discharged from the emergency department (ED) with subsequent positive cultures conducted to determine whether integrating antimicrobial stewardship responsibilities into practice of the emergency medicine clinical pharmacist (EPh) decreased times to positive culture follow-up, patient or primary care provider (PCP) notification, and appropriateness of antimicrobial therapy. Pre- and post-implementation groups of an EPh-managed antimicrobial stewardship program were compared. Positive cultures were identified in 177 patients, 104 and 73 in pre- and post-implementation groups, respectively. Median time to culture review in the pre-implementation group was 3 days (range 1-15) and 2 days (range 0-4) in the post-implementation group (P = .0001). There were 74 (71.2%) and 36 (49.3%) positive cultures that required notification in the pre- and post-implementation groups, respectively, and the median time to patient or PCP notification was 3 days (range 1-9) and 2 days (range 0-4) in the 2 groups (P = .01). No difference was seen in the appropriateness of therapy. In conclusion, EPh involvement reduced time to positive culture review and time to patient or PCP notification when indicated.
authors.affiliation: Department of Pharmacy, University of Kentucky HealthCare, Lexington, KY 40536, USA. stephnbaker@uky.edu
authors.forename: Stephanie N
authors.initials: SN
authors.lastname: Baker
authors.forename: Nicole M
authors.initials: NM
authors.lastname: Acquisto
authors.forename: Elizabeth Dodds
authors.initials: ED
authors.lastname: Ashley
authors.forename: Rollin J
authors.initials: RJ
authors.lastname: Fairbanks
authors.forename: Suzanne E
authors.initials: SE
authors.lastname: Beamish
authors.forename: Curtis E
authors.initials: CE
authors.lastname: Haas
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000890:Anti-Infective Agents / Q000008:administration & dosage*; D001424:Bacterial Infections / Q000188:drug therapy*; D016022:Case-Control Studies; D046508:Culture Techniques / Q000379:methods; D004352:Drug Resistance, Microbial / Q000187:drug effects*; D004636:Emergency Service, Hospital; D005260:Female; D005500:Follow-Up Studies; D006760:Hospitalization; D006801:Humans; D008297:Male; D008875:Middle Aged; D010351:Patient Discharge; D010595:Pharmacists / Q000592:standards*; D010607:Pharmacy Service, Hospital / Q000592:standards*; D012189:Retrospective Studies; D055815:Young Adult
chemical_list: D000890:Anti-Infective Agents
references.citation: J Emerg Med. 2012 Apr;42(4):371-8
references.pmid: 20813484
references.citation: Clin Infect Dis. 2006 Jul 1;43(1):25-31
references.pmid: 16758414
references.citation: Clin Infect Dis. 2007 Jan 15;44(2):159-77
references.pmid: 17173212
references.citation: Crit Care Med. 2010 Apr;38(4):1045-53
references.pmid: 20048677
references.citation: Am J Health Syst Pharm. 2004 May 1;61(9):934-7
references.pmid: 15156970
references.citation: Crit Care Med. 2006 Jun;34(6):1589-96
references.pmid: 16625125
references.citation: Am J Health Syst Pharm. 2008 Mar 1;65(5):395-6, 398-9
references.pmid: 18281729
references.citation: Am J Hosp Pharm. 1977 Aug;34(8):843-6
references.pmid: 900137